Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
Tevogen Bio Holdings (Nasdaq: TVGN) announced that its Chief Information Officer and Head of Tevogen.AI, Mittul Mehta, will participate in the Startup Forum panel at the Databricks DATA + AI World Tour on October 8, 2025, in Boston.
The panel will focus on how early-stage companies are scaling with Databricks, featuring industry leaders including Chris Gervais from Codametrix and Stavros Papadopoulos from TileDB. Mehta will discuss Tevogen.AI's PredicTcell™ platform, developed with Microsoft and Databricks, which aims to accelerate precision immunotherapy development.
Tevogen Bio Holdings (Nasdaq: TVGN) ha annunciato che il proprio Chief Information Officer e responsabile di Tevogen.AI, Mittul Mehta, parteciperà al panel del Startup Forum al Databricks DATA + AI World Tour l'8 ottobre 2025 a Boston.
Il panel verterà su come le aziende in fase iniziale stanno crescendo con Databricks e vedrà la partecipazione di leader del settore come Chris Gervais di Codametrix e Stavros Papadopoulos di TileDB. Mehta parlerà della piattaforma PredicTcell™ di Tevogen.AI, sviluppata con Microsoft e Databricks, che mira ad accelerare lo sviluppo di immunoterapie di precisione.
Tevogen Bio Holdings (Nasdaq: TVGN) anunció que su Chief Information Officer y director de Tevogen.AI, Mittul Mehta, participará en el panel del Startup Forum en el Databricks DATA + AI World Tour el 8 de octubre de 2025 en Boston.
El panel se centrará en cómo las empresas en fase inicial están escalando con Databricks e incluirá a líderes del sector como Chris Gervais de Codametrix y Stavros Papadopoulos de TileDB. Mehta comentará la plataforma PredicTcell™ de Tevogen.AI, desarrollada con Microsoft y Databricks, que busca acelerar el desarrollo de inmunoterapias de precisión.
Tevogen Bio Holdings (Nasdaq: TVGN)는 최고정보책임자(CIO) 겸 Tevogen.AI 책임자인 Mittul Mehta가 2025년 10월 8일 보스턴에서 열리는 Databricks DATA + AI World Tour의 Startup Forum 패널에 참여한다고 발표했습니다.
이번 패널은 Databricks를 활용해 초기 단계 기업들이 어떻게 확장하고 있는지에 초점을 맞추며, Codametrix의 Chris Gervais와 TileDB의 Stavros Papadopoulos 등 업계 리더들이 참여합니다. Mehta는 Microsoft 및 Databricks와 공동 개발한 Tevogen.AI의 PredicTcell™ 플랫폼에 대해 논의할 예정이며, 이 플랫폼은 정밀 면역치료 개발을 가속화하는 것을 목표로 합니다.
Tevogen Bio Holdings (Nasdaq: TVGN) a annoncé que son Chief Information Officer et responsable de Tevogen.AI, Mittul Mehta, participera au panel du Startup Forum lors du Databricks DATA + AI World Tour le 8 octobre 2025 à Boston.
Le panel portera sur la façon dont les entreprises en phase initiale se développent avec Databricks et réunira des leaders du secteur tels que Chris Gervais de Codametrix et Stavros Papadopoulos de TileDB. Mehta présentera la plateforme PredicTcell™ de Tevogen.AI, développée avec Microsoft et Databricks, qui vise à accélérer le développement d'immunothérapies de précision.
Tevogen Bio Holdings (Nasdaq: TVGN) gab bekannt, dass sein Chief Information Officer und Leiter von Tevogen.AI, Mittul Mehta, am 8. Oktober 2025 in Boston am Startup-Forum-Panel der Databricks DATA + AI World Tour teilnehmen wird.
Das Panel wird sich darauf konzentrieren, wie Frühphasenunternehmen mit Databricks skalieren, und bringt Branchenführer wie Chris Gervais von Codametrix und Stavros Papadopoulos von TileDB zusammen. Mehta wird über Tevogen.AI's PredicTcell™-Plattform sprechen, die gemeinsam mit Microsoft und Databricks entwickelt wurde und die Entwicklung präziser Immuntherapien beschleunigen soll.
- None.
- None.
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the Startup Forum at the Databricks DATA + AI World Tour on October 8, 2025.
The Startup Forum will feature insights from venture capital leaders and early-stage innovators on how they are scaling their companies with Databricks. Mehta will join industry peers including Chris Gervais, CTO of Codametrix, and Stavros Papadopoulos, CEO of TileDB, in a discussion moderated by Tony Pezzullo, Principal at SignalFire. Mehta will share perspectives on Tevogen.AI’s application of advanced data and AI technologies, including its PredicTcell™ platform, developed in collaboration with Microsoft and Databricks, to accelerate precision immunotherapy development.
Databricks DATA + AI World Tour will take place at the Sheraton Boston Hotel. For more information please contact, communications@tevogen.com
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b86622e6-99bc-4be9-8b77-537a3cb5e357
FAQ
When and where is Tevogen Bio (TVGN) presenting at the Databricks DATA + AI World Tour?
What will Tevogen Bio's CIO discuss at the Databricks conference?
Who are the other panelists joining Tevogen Bio at the Databricks Startup Forum?
How can investors get more information about Tevogen Bio's Databricks presentation?
